The neurofibromatoses. An overview

Italian Journal of Neurological Sciences

Volumn 20, Issue 2, 1999, Pages 89-108

  Ruggieri, M ^a,b,c   Huson, S M ^b  

^a UNIVERSITY OF CATANIA   (Italy)

^b OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^c CNR   (Italy)

Author keywords

Adulthood; Childhood; Classification; Genetics; Mosaic segmental neurofibromatosis; Neurofibromatosis; Neurological manifestations; Nf2; Nfl; Variants

Indexed keywords

CLASSIFICATION; HUMAN; NEUROFIBROMATOSIS; PATHOPHYSIOLOGY; REVIEW;

HUMANS; NEUROFIBROMATOSES;

EID: 0033107688     PISSN: 03920461     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100720050017     Document Type: Article

References (139)

1. Huson SM, Hughes RAC (1994) The neurofibromatoses: pathogenetic and clinical overview. Chapman & Hall, London
2. Gutman DH, Aynsworth A, Carey JC, et al (1997) The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA 278:51-57
3. Ruggieri M, Huson SM (1997) What's new in neurofibromatosis? Curr Pediatr 7:167-176
4. Huson SM (1999) What level of care for the neurofibromatoses. Lancet 353:1114-1116
5. Riccardi VM (1982) Neurofibromatosis: clinical heterogeneity. Curr Probl Cancer 7:1-34
6. Riccardi VM (1992) Neurofibromatosis: phenotype, natural history and pathogenesis. Johns Hopkins University, Baltimore
7. Ruggieri M, Huson SM (1999) The different forms of neurofibromatosis. A review. Eur J Dermatol (in press)
8. Gorlin R, Cohen MM Jr, Levine M (1992) The neurofibromatoses [Nfl Recklinghausen type, Nfll acoustic type, other types]. In: Gorlin R, Cohen MM Jr, Levine M (eds) Syndromes of the head and neck. Oxford University, Oxford, pp 392-399
9. Viskochil D, Carey JC (1992) Nosological considerations of the neurofibromatosis. J Dermatol 19:873-880
10. National Institutes of Health Consensus Development Conference Statement (1988) Neurofibromatosis. Arch Neurol 45:575-578
11. Upadhyaya M, Cooper DN (1998) Neurofibromatosis type 1. From genotype to phenotype. Bios Scientific, Oxford, pp 21-38
12. Hecht F (1989) Recognition of neurofibromatosis before von Recklinghausen. Neurofibromatosis 2:180-184
13. Zanca A, Zanca A ( 1980) Antique illustrations of neurofibromatosis. Int J Dermatol 19:55-58
14. Morse RP (1999) Neurofibromatosis type 1. Arch Neurol 56:364-365
15. North K (1997) Neurofibromatosis type 1 in childhood. McKeith Press, London (International review of child neurology series)
16. Friedman JM, Birch PH (1997) Type 1 neurofibromatosis: a descriptive analysis of the disorder in 1,728 patients. Am J Med Genet 70:138-143
17. McGaughran JM, Harris DI, Donnai D, et al (1999) A clinical study of type 1 neurofibromatosis in north west England. J Med Genet 36:197-203
18. Korf BR ( 1992) Diagnostic outcome in children with multiple cafe-au-lait spots. Pediatrics 90:924-927
19. Crowe FW (1964) Axillary freckling as a diagnostic aid in neurofibromatosis. Ann Intern Med 61:1142-1143
20. Korf BR, Huson SM, Needle M, et al (1997) Report on the working group on neurofibroma. National Neurofibromatosis Foundation, Boston, pp 4-27
21. Dugoff L, Sujansky E ( 1996) Neurofibromatosis type 1 and pregnancy. Am J Med Genet 66:7-10
22. Huson SM, Jones D, Beck L (1987) Ophthalmic manifestations of neurofibromatosis. Br J Ophthalmol 71:235-238
23. Zvulunov A, Barak Y, Metzker A (1995) Juvenile xanthogranuloma, neurofibromatosis, and juvenile chronic myelogenic leukemia: world statistical analysis. J Am Acad Dermatol 131:904-908
24. Gutman DH, Gurney JG, Shannon KM (1996) Juvenile xanthogranuloma, neurofibromatosis 1 and juvenile chronic leukemia. Arch Dermatol 132:1390-1391
25. Werteleki W, Superneau DW, Forehand LW, Hoff ET (1988) Angiomas and von Recklinghausen neurofibromatosis. Neurofibromatosis 1:137-145
26. Cnossen MH, Moon KGM, Garssen MPJ et al (1998) Minor disease features in neurofibromatosis type 1 (Nfl) and their possible value in diagnosis of Nfl children < 6 years and clinically suspected of having Nfl. J Med Genet 35:624-627
27. Huson SM, Harper PS, Compston DAS (1988) Von Recklinghausen neurofibromatosis. Brain 111:1355-1381
28. North KN, Riccardi VM, Samango-Sprouse C, et al (1997) Cognitive function and academic performance in neurofibromatosis type 1. Neurology 48:1121 -1127
29. Crèange A, Zeller J, Rostaing-Rigattieri S, et al (1999) Neurological complications of neurofibromatosis type 1 in adulthood. Brain 122:473-481
30. Silva AJ, Franckland PW, Marowitz Z, et al (1997) A mouse model for the neurological deficits associated with neurofibromatosis type 1. Nat Genet 15:281-284
31. DiMario FJ, Ramsby G (1998) Magnetic resonance imaging lesion analysis in neurofibromatosis type 1. Arch Neurol 55:500-505
32. DiPaolo DP, Zimmerman RA, Rorke LB, et al (1995) Neurofibromatosis type 1 : pathologic substrate of high signal intensity foci in the brain. Radiology 195:721-724
33. Inoue Y, Nemoto Y, Tashiro T, Nakayama K, Nakayama T, Daikokuya H (1997) Neurofibromatosis type 1 and type 2: review of the central nervous system and related structures. Brain Dev 19:1-12
34. Gutman DH (1998) Recent insights into neurofibromatosis type 1: clear genetic progress. Arch Neurol 55:778-780
35. Balestri P, Lucignani G, Fois A, et al (1994) Cerebral glucose metabolism in neurofibromatosis type 1 assessed with [18 F]fluoro-2-deoxy-D-glucose and PET. J Neurol Neurosurg Psychiatry 57:1479-1483
36. Castillo M, Kwock L, Green C, Shiro S, Wilson D, Greenwood R (1996) Proton MR spectroscopy in a possible enhancing hamartoma in a patient with Nfl. AJNR Am J Neuroradiol 16:993-996
37. Castillo M, Green C, Kwick L, et al (1995) Proton MR in patients with neurofibromatosis type 1 : evaluation of hamartomas and possible clinical evaluation. AJNR Am J Neuroradiol 16:141-147
38. Bilaniuk LT, Molloy PT, Zimmerman RA, et al (1997) Neurofibromatosis type 1: brain stem tumours. Neuroradiology 39:642-653
39. Bonawitz C, Castillo M, Chin CT, Mukherjii SK, Barkowich AJ (1998) Usefulness of contrast material in MR of patients with neurofibromatosis type 1. AJNR Am J Neuroradiol 19:541-543
40. Listernick R, Louis DN, Packer RJ, Gutman DH ( 1997) Optic pathways glioma in children with neurofibromatosis type 1 : consensus statement from the Optic Pathway Glioma Task Force. Ann Neurol 41:143-149
41. Parazzini C, Triulzi F, Bianchini E, et al (1995) Spontaneous involution of optic pathway lesions in neurofibromatosis type 1: serial contrast evaluation. AJNR Am J Neuroradiol 16:1711-1718
42. Cnossen MH, Stam EN, Cooiman LC, et al (1997) Endocrinologie disorders and optic pathway gliomas in children with neurofibromatosis type 1. Pediatrics 100:667-670
43. Pollack IF, SchultzB, Mulrihill JJ (1996) The management of brainstem gliomas in patients with neurofibromatosis type 1. Neurology 46:1652-1660
44. Boniscer A, Gajjar A, Bhargava R, et al (1997) Brain stem involvement in children with neurofibromatosis type 1 : role of magnetic resonance imaging and spectroscopy in the distinction from diffuse pontine glioma. Neurosurgery 40:331-338
45. Wolkenstein P, Freche B, Zeller J, Revuz J (1996) Usefulness of screening investigations in neurofibromatosis type 1. A study of 152 patients. Arch Dermatol 132:1333-1336
46. Korf BR, Carrazana E, Holmes GL (1993) Patterns of seizures observed in association with neurofibromatosis type 1. Epilepsia 34:616-620
47. Korf BR (1997) Neurocutaneous syndromes: neurofibromatosis 1, neurofibromatosis 2, and tuberous sclerosis. Curr Opin Neurol 10:131-136
48. Kulkantrakorn K, Geller TJ (1999) Seizures in neurofibromatosis type 1(NF1). Pediatr Neurol 19:347-350
49. Motte J, Billard C, Fejerman N, Sfaello Z, Arroyo H, Dulac O (1993) Neurofibromatosis type 1 and West syndrome: a relatively benign association. Epilepsia 34:723-726
50. Fois A, Tine' A, Pavone L (1994) Infantile spasms in patients with neurofibromatosis type 1. Childs Nerv Syst 10:176-179
51. Clementi M, Battistella PA, Rizzi L, Boni S, Tenconi R ( 1996) Headache in patients with neurofibromatosis type I. Headache 36:10
52. Senveli E, Altinors N, Kars Z, et al (1989) Association of von Recklinghausen's neurofibromatosis and acqueduct stenosis. Neurosurgery 24:99-101
53. Rubinstein LJ (1986) The malformative central nervous system lesions in the central and peripheral forms of neurofibromatosis. A neuropathological study of 22 cases. Ann N Y Acad Sei 486:14-29
54. Rizzo JF, Lessell S (1994) Cerebrovascular abnormalities in neurofibromatosis type 1. Neurology 44:1000-1002
55. Erkulvrawater S, Gammal TE, Hawkins J, et al (1979) Intrathoracic meningoceles and neurofibromatosis. Arch Neurol 36:557-559
56. Thomas PK, King RHM, Chiang TR, Scaravilli F, Sharma AK, Downie AW (1990) Neurofibromatous neuropathy. Muscle Nerve 13:93-101
57. Ferner RE, Upadhyaya M, Osborn M, Hughes RAC (1996) Neurofibromatous neuropathy. J Neurol 243[S2]:S20
58. Johnson MR, Ferner RE, Hughes RAC, Bobrow M (1996) Mutation analysis of the oligodendrocyte-myelin glycoprotein gene in five patients with both neurofibromatosis and primary progressive multiple sclerosis. J Neurol 243:81
59. Kleihues P, Cavenee WK (1997) Pathology and genetics of tumours of the nervous system. International Agency for Research on Cancer, Lyon, pp 171-192, 215-249
60. Alison J, Ruggieri M, Ferner RE, Upadhyaya M (1998) Characterisation of a second hit in a plexiform neurofibroma from an Nfl patient. Am J Hum Genet 63(S):A366
61. Needle MN, Cnaan A, Dattilo J, et al (1997) Prognostic signs in the surgical management of plexiform neurofibroma: the Children's Hospital of Philadelphia experience. J Pediatr 131:678-682
62. Ruggieri M, Pavone V, DeLuca D, Franzo' A, Tine' A, Pavone L (1998) Congenital bone malformations in neurofibromatosis type 1. J Pediatr Orthop (in press)
63. Ruggieri M, Pavone V, Polizzi A, et al (1998) Unusual giant cell granuloma of the mandible and lower limbs in a patient with neurofibromatosis type 1. Oral Surg Oral Med Oral Pathol Endodontics 87:67-72
64. Ruggieri M, Pavone V, Tine' A, et al (1996) Ossifying fibroma of the skull in a patient with neurofibromatosis type I. J Neurosurg 85:941-944
65. Griffiths D, Williams G, Williams E (1997) Duodenal carcinoid tumours, phaeochromocytoma and neurofibromatosis: islet cell tumour, phaeochromocytoma and the von HippelLindau complex: two distinctive neuroendocrine syndromes. Q J Med, 245:769-782
66. Shen MH, Harper PS, Upadhyaya M ( 1996) Molecular genetics of neurofibromatosis type 1. J Med Genet 33:2-17
67. Barker D, Wright E, Nguyen K, et al (1987) Gene for von Recklinghausen neurofibromatosis is in the pericentromeric region of chromosome 17. Science 236:1100-1102
68. Seizinger BR, Rouleau GA, Ozelius LG, et al (1987) Genetic linkage of von Recklinghausen neurofibromatosis to the nerve growth factor receptor gene. Cell 49:589-594
69. Cawthon RM, Weiss R, Xu G, et al (1990) A major segment of the neurofibromatosis type 1 gene: DNA sequence, genomic structure and point mutations. Cell 62:193-201
70. Vischocil D, Buchberg AM, Xu G, et al (1990) Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus. Cell 62:187-192
71. Wallace MR, Marchuk DA, Andersen LB, et al (1990) Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three Nfl patients. Science 249:181-186
72. Gutman DH, Wood DL, Collins FS (1991) Identification of the neurofibromatosis type 1 gene. Proc Natl Acad Sei USA 88:9914-9918
73. Wu BL, Austin MA, Gretchen H, Schneider GH, Boles RG, Korf BR (1995) Deletion of the entire Nfl gene detected by FISH: four deletion patients associated with severe manifestations. Am J Med Genet 59:528-535
74. Upadhyaya M, Maynard J, Ruggieri M, et al (1997) A sex bias in the origin of new mutations in the Nfl gene: the nature of mutations and their possible molecular mechanisms. Am J HumGenet61[S4]:A349
75. Upadhyaya M, Ruggieri M, Maynard J, et al (1998) Gross deletions of the neurofibromatosis type 1 gene (Nfl) are predominantly of maternal origin and commonly associated with a learning disability, dysmorphic features and developmental delay. Hum Genet 102:591-597
76. Huson SM, Ruggieri M (1999) The neurofibromatoses. In: Harper J, Oranje JM, Rose M (eds) Textbook of paediatric dermatology. Blackwell Science, Oxford (in press)
77. Moss C, Green SH (1994) What is segmental neurofibromatosis? Br J Dermatol 130:106-110
78. Ingordo V, D'Andria G, Mendicini S, Grecucci M, Baglivo A (1995) Segmental neurofibromatosis: is it uncommon or underdiagnosed? Arch Dermatol 131:959-960
79. Wolkenstein P, Mahmoudi A, Zeller J, Revuz J (1995) More on the frequency of segmental neurofibromatosis. Arch Dermatol 131:1465
80. Ruggieri M (1996) Neurofibromatosi segmentale. In: Balestrazzi P (ed) Neurofibromatosi. Atti del 2° Congresso Nazionale. Editrice C.S.H, Milan, pp 65-75
81. Gammel JA (1931) Localized neurofibromatosis. Arch Dermatol 24:712-713
82. Crowe FW, Schull WJ, Neel JV (1956) A clinical, pathological, and genetic study of multiple neurofibromatosis. Charles C. Thomas, Springfield
83. Miller RM, Sparkes RS (1977) Segmental neurofibromatosis. Arch Dermatol 113:837-838
84. Roth R, Marlines M, James W (1987) Segmental neurofibromatosis. Arch Dermatol 123:917-920
85. Happle RH (1996) Segmental forms of autosomal dominant skin disorders: different types reflect different states of zygosity. Am J Med Genet 66:241-242
86. Happle RH (1997) A rule concerning the segmental manifestation of autosomal dominant skin disorders. Review of clinical examples providing evidence for dichotomous types of severity. Arch Dermatol 133:1505-1509
87. Uhlin SR (1980) Segmental neurofibromatosis. South Med J 73:526-527
88. Rubenstein A, Bader JL, Aron AA, Wallace S (1983) Familial transmission of segmental neurofibromatosis. Neurology 33(S2):76
89. Riccardi VM, Lewis RA (1988) Penetrance of von Recklinghausen neurofibromatosis: a distinction between predecessors and descendants. Am J Hum Genet 42:284-289
90. Boltshauer E, Stocker H, Machler M (1989) Neurofibromatosis type 1 in a child of a parent with segmental neurofibromatosis (NF-5). Neurofibromatosis 2:244-245
91. Segal R, Wenger SL, Pollack I (1991) Chromosome translocation and familial transmission in segmentai neurofibromatosis. Presented at the Joint Section on Disorders of the Spine and Peripheral Nerves, California, 13-17 February 1991, p 40
92. Lazaro C, Ravella A, Gaona A, Volpini V, Estivilli X (1994) Neurofibromatosis type 1 due to germ-line mosaicism in a clinially normal father. N Engl J Med 331:1403-1407
93. Ainsworth PJ, Weksberg R, Shuman C (1995) Somatic mosaicism in a case of sporadic neurofibromatosis. Am J Hum Genet 57[Suppl]:440
94. Ainsworth PJ, Chakraborthy PK, Weksberg R (1997) Example of somatic mosaicism in a series of de novo neurofibromatosis type 1 cases due to a maternally derived deletion. Hum Mutât 9:458-464
95. Colman SD, Rasmussen SA, Ho VT, Abernathy CR, Wallace MR ( 1996) Somatic mosaicism in a patient with neurofibromatosis type 1. Am J Hum Genet 58:484-490
96. Evans DGR, Huson SM, Neary W, et al (1992) A clinical study of type 2 neurofibromatosis. Q J Med 304:603-618
97. Evans DGR, Huson SM, Donnay D, et al (1992) A genetic study of type 2 neurofibromatosis in the United Kingdom. I. Prevalence, mutation rate, fitness, and confirmation of maternal transmission effect on severity. J Med Genet 29:841-846
98. Parry DM, Eldridge R, Kaiser-Kupfer MI, Bouzas EA, Pikus A, Patronas N ( 1994) Neurofibromatosis type 2: clinical characteristics of 63 affected individuals and clinical evidence for heterogeneity. Am J Med Genet 52:450-454
99. Wishart J ( 1822) Cases of tumours in the skull, dura mater and brain. Edinb Med Surg J 18:393-397
100. Henneberg R, Koch M (1903) Ueber "zentrale" Neurofibromatose und die Geschwülste des Kleinhirnbruckenwinkels (Acusticsneurome). Arch F Psychiatr 36:251
101. Gardiner WT, Frazier CH (1930) Bilateral acoustic neurofibromas: a clinical study and field survey of a family of five generations with bilateral deafness in 38 members. Arch Neurol Psych 23:266-300
102. Young DF, Eldridge R, Gardner WJ (1970) Bilateral acoustic neuromas in a large kindred. JAMA 214:393-397
103. Mautner VF, Tatagiba M, Guthoff R, Samili M, Pulst SM (1993) Neurofibromatosis type 2 in the paediatric age group. Neurosurgery 33:92-96
104. -(1992) National Institutes of Health Consensus Development Conference Statement on Acoustic Neuroma, December 11 -13, 1991. Arch Neurol 51:201 -207
105. Mautner VF, Lindenau M, Baser ME, et al (1996) The neuroimaging and clinical spectrum of neurofibromatosis type 2. Neurosurgery 38:880-886
106. Mautner VF, Lindenau M, Baser ME, Kluwe L, Gottschalk J (1997) Skin abnormalities in neurofibromatosis type 2. Arch Dermatol 133:1539-1543
107. Kaiser-Kupfer MI, Freidlin V, Datiles MB, et al (1989) The association of posterior capsular lens opacities with bilateral acoustic neuromas in patients with neurofibromatosis type 2. Arch Ophthalmol 107:541-544
108. Ragge NK, Baser ME, Klein J, et al (1995) Ocular abnormalities in neurofibromatosis 2. Am J Ophthalmol 120:634-641
109. Seizinger BR, Martuza RL, Gusella JF, et al (1986) Loss of genes on chromosome 22 in tumorogenesis of human acoustic neuroma. Nature 322:644-647
110. Rouleau G, Seizinger BR, Ozelius LG, et al (1987) Genetic linkage analysis of bilateral acoustic neurofibromatosis to a DNA marker on chromosome 22. Nature 329:246-248
111. Rouleau GA, Merel P, Luchman M, et al (1993) Alteration in a new gene encoding a putative membrane-organising protein causes neurofibromatosis type 2. Nature 363:515-521
112. Troffater JA, Mac Collin MM, Rutter JL, et al ( 1993) A novel moesin, ezrin-, radixin-like gene is candidate for the neurofibromatosis type 2. Cell 72:791-800
113. Ruttledge MH, Andermann AA, Phelan CM, et al (1996) Type of mutation in the neurofibromatosis type 2 gene (NF2) frequently determines severity of disease. Am J Hum Genet 59:331-342
114. Evans DGR, Trueman L, Wallace A, Collins S, Strachan T (1998) Genotype/phenotype correlation in type 2 neurofibromatosis (NF2): evidence for more severe disease associated with truncating mutations. J Med Genet 35:450-455
115. McKusick VA (1998) Mendelian inheritance in man: a catalog of human genes and genetic disorders, 12th edn. Johns Hopkins University Press, Baltimore
116. Purcell S, Dixon SL (1989) Schwannomatosis. An unusual variant of neurofibromatosis or a distinct clinical entity? Arch Dermatol 125:390-393
117. MacCollin M, Woodfin W, Kronn D, Short MP (1996) Schwannomatosis: a clinical and pathologic study. Neurology 46:1072-1079
118. Pulst SM, Riccardi VM, Mautner V (1997) Spinal Schwannomatosis. Neurology 48:1923-1925
119. Evans DGR, Mason D, Huson SM, Ponder M, Harding AE, Strachan T (1997) Spinal and cutaneous Schwannomatosis is a variant form of type 2 neurofibromatosis. A clinical and molecular study. J Neurol Neurosurg Psychiatry 62:361-366
120. MacCollin M, Jacoby LB, Davis K, et al (1996) Clinical and molecular characterization of "segmental" neurofibromatosis 2. Presented at the FASEB Summer Research Conference on Neurofibromatosis, 29 June - 4 July 1996, Snowmass, USA
121. Pulst S, Riccardi VM, Fain P, Korenberg JR (1991) Familial spinal neurofibromatosis: clinical and DNA linkage analysis. Neurology 41:1923-1927
122. Pohyonen M, Leisti E-L, Kytola S, Leisti J (1997) Hereditary spinal neurofibromatosis: a rare form of Nfl. J Med Genet 34:184-187
123. Ars E, Kruyer H, Gaona A, et al (1998) A clinical variant of neurofibromatosis type 1 : familial spinal neurofibromatosis with a frameshift mutation in the Nfl gene. Am J Hum Genet 62:834-841
124. Hashemian H (1953) Familial fibromatosis of small intestine. Br J Surg 40:346-350
125. Manley KA, Skyring AP ( 1961 ) Some heritable causes of gastrointestinal disease: special reference to haemorrhage. Arch Intern Med 107:182-203
126. Lipton S, Zuckerbrod M (1966) Familial enteric neurofibromatosis. Med Times 94:544-548
127. Heimann R, Verhest A, Verschraegen J, Grosjean W, Draps JP, Hicht F (1988) Hereditary intestinal neurofibromatosis. A distinctive genetic disease. Neurofibromatosis 1:26-32
128. Verhest A, Verschraegen J, Grosjean W, Heimann R (1981) Transmissible chromosome abnormality in familial intestinal neurofibromatosis. Presented at the 6th International Congress of Human Genetics, Jerusalem, p 176
129. Verhest A, Verschraegen J, Grosjean W, Draps JP, Vamos E (1988) Hereditary intestinal neurofibromatosis. Translocation between chromosomes. Neurofibromatosis 2:33-36
130. Brunner HG, Hulsebos T, Steijlen PM, der Rinderen D, van der Steen A, Hamel BCJ (1993) Exclusion of the neurofibro-matosis 1 locus in a family with inherited cafe'-au-lait spots. Am J Med Genet 46:472-474
131. Charrow J, Listernik R, Ward K (1993) Autosomal dominant multiple cafe-au-lait spots and neurofibromatosis. Am J Med Genet 45:606-608
132. Abeliovich D, Gelman-Kohan Z, Silverstein S, et al (1995) Familial café-au-lait spots: a variant of neurofibromatosis type 1. J Med Genet 32:985-986
133. Pagan K, Suthers OK, Hardacre G (1988) Ring chromosome 11 and café-au-lait spots. Am J Med Genet 30:911-916
134. Korf B, Prasad C, Schneider G, Anthony D (1996) A family with multiple neurofibromas and non-linkage to Nf 1 or Nf2. Presented at the FASEB Summer Research Conference on Neurofibromatosis, 29 June - 4 July 1996, Snowmass, USA
135. Watson GH (1967) Pulmonary stenosis, café-au-lait spots, and dull intelligence. Arch Dis Child 42:303-307
136. Allanson JE, Upadhyaya M, Watson G, et al (I991) Watson syndrome: is it a subtype of type 1 neurofibromatosis? J Med Genet 28:752-756
137. Tassabehji M, Strachan T, Sharland M, et al (1993) Tandem duplication within a neurofibromatosis type I (Nf I ) gene exon in a family with features of Watson syndrome and Noonan syndrome. Am J Hum Genet 53:90-95
138. Carey JC (1998) Neurofibromatosis-Noonan syndrome. Am J Med Genet 75:263-264
139. Gorlin RJ, Koutlas IG (1998) Multiple schwannomas, multiple nevi, and multiple vaginal leiomyomas: a new dominant syndrome. Am J Med Genet 78:76-81